Apixaban Tablets
Formulation (FDF) · Tablets · 2.5mg, 5mg
Formulation (FDF)Confidentiality：Public
- INN / Generic Name
- Apixaban Tablets
- Dosage Form
- Tablets
- Strength
- 2.5mg, 5mg
- Therapy Area
- Cardiovascular
- Indication
- Stroke prophylaxis; Systemic embolism prophylaxis; Deep vein thrombosis; Venous thromboembolism prophylaxis; Pulmonary embolism; Recurrent deep vein thrombosis prophylaxis; Recurrent pulmonary embolism prophylaxis
- Current Status
- Official FDF licensing catalog (UB870)
- GMP Certification
- US - FDA
- CEP
- No
- DMF Type
- —
- Stability Data
- —
- BE Required
- Not required / waivable
- Registration Pathway
- Registered (market rights transferable / DCP·NP per market)
- MOQ
- On request
- Lead Time
- On request
- Price Range
- On request
HS Code
3004.903 customs bills on file
Registrable Markets
United States
Process / Sequence / Exact Price
- Process Summary
- —
- Exact Price